Join to View Full Profile
1600 Sw Archer RdPob 100265Gainesville, FL 32610
Phone+1 352-273-9000
Dr. Dayton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Orrin Louis Dayton IV, MD, is a neuroradiologist based in Gainesville, FL. He completed his residency in Diagnostic Radiology in 2020 and fellowship in Neuroradiology in 2021 at University of Florida, after graduating from Wake Forest School of Medicine in 2012. Dr. Dayton has authored multiple publications, including research on the effects of COVID-19 vaccines on Parkinson's disease, predictors of outcomes after aneurysmal subarachnoid hemorrhage, and case reports on conditions such as ameloblastoma and sphenoid sinusitis. His work has been cited in various academic journals, contributing to the fields of immunology, neurointerventional surgery, oral oncology, and clinical imaging.
Education & Training
University of FloridaFellowship, Neuroradiology, 2020 - 2021- University of FloridaResidency, Radiology-Diagnostic, 2016 - 2020
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2012
Certifications & Licensure
FL State Medical License 2020 - 2026
American Board of Radiology Diagnostic Radiology- American Board of Radiology Neuroradiology
Publications & Presentations
PubMed
- 4 citationsDecrease in cortical vein opacification predicts outcome after aneurysmal subarachnoid hemorrhage.William S Dodd, Orrin Dayton, Brandon Lucke-Wold, Christian Reitano, Zachary Sorrentino
Journal of Neurointerventional Surgery. 2023-11-01 - 2 citationsAnalyzing the effect of the COVID-19 vaccine on Parkinson's disease symptoms.Revati Sabat, Orrin L Dayton, Amit Agarwal, Vinata Vedam-Mai
Frontiers in Immunology. 2023-01-01 - 10 citationsManaging stage 4 ameloblastoma with dual BRAF/MEK inhibition: A case report with 8-year clinical follow-up.Zachary Abramson, Orrin L Dayton, Walter E Drane, William M Mendenhall, Frederic J Kaye
Oral Oncology. 2022-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
